CEO.CA SEDI filings for

SEDI Insider filing browser

Date	Issuer	Insider	Transaction	Amount	New Balance ⓘ The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-03-13 17:55 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-7,407 vol	433,500
Filed 2024-03-13 17:55 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-1,234 vol	440,907
Filed 2024-03-13 17:55 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-283,263.40 -6,118 vol $46.30 each	8,398
Filed 2024-03-13 17:54 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-47,026.85 -1,019 vol $46.15 each	14,516
Filed 2024-03-13 17:54 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-59,242.44 -1,289 vol $45.96 each	15,535
Filed 2024-03-13 17:53 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$72,958 +7,407 vol $9.85 each	16,824
Filed 2024-03-13 17:53 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-9,881.40 -215 vol $45.96 each	9,417
Filed 2024-03-13 17:52 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$12,154 +1,234 vol $9.85 each	9,632
Filed 2024-03-13 17:50 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Holder: 9465-2138 Québec inc. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-92,402.40 -2,000 vol $46.20 each	2,000
Filed 2024-03-13 17:50 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Holder: 9465-2138 Québec inc. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-231,512.50 -5,000 vol $46.30 each	4,000
Filed 2024-03-13 17:50 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Holder: 9465-2138 Québec inc. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-231,250 -5,000 vol $46.25 each	9,000
Filed 2024-03-13 17:49 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Holder: 9465-2138 Québec inc. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-46,450 -1,000 vol $46.45 each	14,000
Filed 2024-03-13 17:40 Tx date 2024-03-08	$XENE Xenon Pharmaceuticals Inc.	Garofalo, Elizabeth 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-3,500 vol	52,975
Filed 2024-03-13 17:36 Tx date 2024-03-08	$XENE Xenon Pharmaceuticals Inc.	Garofalo, Elizabeth 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-95,583.48 -2,092 vol $45.69 each	0
Filed 2024-03-13 17:34 Tx date 2024-03-08	$XENE Xenon Pharmaceuticals Inc.	Garofalo, Elizabeth 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-64,993.28 -1,408 vol $46.16 each	2,092
Filed 2024-03-13 17:33 Tx date 2024-03-08	$XENE Xenon Pharmaceuticals Inc.	Garofalo, Elizabeth 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$64,959 +3,500 vol $18.56 each	3,500
Filed 2024-03-13 17:25 Tx date 2021-06-03	$XENE Xenon Pharmaceuticals Inc.	Garofalo, Elizabeth 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2024-03-13 17:16 Tx date 2024-03-08	$XENE Xenon Pharmaceuticals Inc.	Garofalo, Elizabeth 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-3,500 vol
Filed 2024-03-12 19:17 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Holder: 9465-2138 Québec inc. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-92,402.40 -2,000 vol $46.20 each
Filed 2024-03-12 19:16 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Holder: 9465-2138 Québec inc. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-231,512.50 -5,000 vol $46.30 each
Filed 2024-03-12 19:15 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Holder: 9465-2138 Québec inc. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-231,250 -5,000 vol $46.25 each
Filed 2024-03-12 19:15 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Holder: 9465-2138 Québec inc. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-46,450 -1,000 vol $46.45 each
Filed 2024-03-11 17:07 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-7,407 vol
Filed 2024-03-11 17:06 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-1,234 vol
Filed 2024-03-11 17:02 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-283,263.40 -6,118 vol $46.30 each
Filed 2024-03-11 17:02 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-47,026.85 -1,019 vol $46.15 each
Filed 2024-03-11 17:01 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-59,242.44 -1,289 vol $45.96 each
Filed 2024-03-11 17:00 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$72,958 +7,407 vol $9.85 each
Filed 2024-03-11 16:59 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-9,881.40 -215 vol $45.96 each
Filed 2024-03-11 16:58 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$12,154 +1,234 vol $9.85 each
Filed 2024-03-12 19:17 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Holder: 9465-2138 Québec inc. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-92,402.40 -2,000 vol $46.20 each	2,000
Filed 2024-03-12 19:16 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Holder: 9465-2138 Québec inc. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-231,512.50 -5,000 vol $46.30 each	4,000
Filed 2024-03-12 19:15 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Holder: 9465-2138 Québec inc. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-231,250 -5,000 vol $46.25 each	9,000
Filed 2024-03-12 19:15 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Holder: 9465-2138 Québec inc. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-46,450 -1,000 vol $46.45 each	14,000
Filed 2024-03-11 17:07 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-7,407 vol	433,500
Filed 2024-03-11 17:06 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-1,234 vol	440,907
Filed 2024-03-11 17:02 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-283,263.40 -6,118 vol $46.30 each	8,398
Filed 2024-03-11 17:02 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-47,026.85 -1,019 vol $46.15 each	14,516
Filed 2024-03-11 17:01 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-59,242.44 -1,289 vol $45.96 each	15,535
Filed 2024-03-11 17:00 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$72,958 +7,407 vol $9.85 each	16,824
Filed 2024-03-11 16:59 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-9,881.40 -215 vol $45.96 each	9,417
Filed 2024-03-11 16:58 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$12,154 +1,234 vol $9.85 each	9,632
Filed 2024-03-11 16:49 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-283,263.40 -6,118 vol $46.30 each
Filed 2024-03-11 16:49 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-47,026.85 -1,019 vol $46.15 each
Filed 2024-03-11 16:48 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-59,242.44 -1,289 vol $45.96 each
Filed 2024-03-11 16:48 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$72,958 +7,407 vol $9.85 each
Filed 2024-03-11 16:48 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-9,881.40 -215 vol $45.96 each
Filed 2024-03-11 16:48 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$12,154 +1,234 vol $9.85 each
Filed 2024-03-11 15:30 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-283,263.40 -6,118 vol $46.30 each	442,141
Filed 2024-03-11 15:30 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-283,263.40 -6,118 vol $46.30 each
Filed 2024-03-11 15:26 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-47,026.85 -1,019 vol $46.15 each	448,259
Filed 2024-03-11 15:26 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-47,026.85 -1,019 vol $46.15 each
Filed 2024-03-11 15:25 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-59,242.44 -1,289 vol $45.96 each	449,278
Filed 2024-03-11 15:25 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-59,242.44 -1,289 vol $45.96 each
Filed 2024-03-11 15:24 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$72,958 +7,407 vol $9.85 each	450,567
Filed 2024-03-11 15:24 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$72,958 +7,407 vol $9.85 each
Filed 2024-03-11 15:21 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-9,881.40 -215 vol $45.96 each	443,160
Filed 2024-03-11 15:21 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-9,881.40 -215 vol $45.96 each
Filed 2024-03-11 15:19 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$12,154 +1,234 vol $9.85 each	443,375
Filed 2024-03-11 15:19 Tx date 2024-03-07	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$12,154 +1,234 vol $9.85 each
Filed 2024-01-03 13:24 Tx date 2023-12-29	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	-8,398 vol	8,398
Filed 2023-12-20 17:57 Tx date 2023-12-19	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$37,697 +3,497 vol $10.78 each	74,225
Filed 2023-12-20 17:55 Tx date 2023-12-19	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-37,697.66 -3,497 vol $10.78 each	101,705
Filed 2023-12-20 17:52 Tx date 2023-12-19	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$8,871 +823 vol $10.78 each	70,728
Filed 2023-12-20 17:50 Tx date 2023-12-19	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-8,871.94 -823 vol $10.78 each	105,202
Filed 2023-12-18 15:46 Tx date 2023-12-14	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-311,897.90 -7,598 vol $41.05 each	4,902
Filed 2023-12-18 15:41 Tx date 2023-12-13	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-158,443.68 -3,977 vol $39.84 each	23,573
Filed 2023-12-18 15:39 Tx date 2023-12-13	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$35,793 +3,977 vol $9.00 each	27,550
Filed 2023-12-18 15:35 Tx date 2023-12-13	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-12,580.26 -1,167 vol $10.78 each	96,561
Filed 2023-12-18 15:33 Tx date 2023-12-13	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-42,872.06 -3,977 vol $10.78 each	97,728
Filed 2023-12-18 15:29 Tx date 2023-12-13	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-90,047.30 -2,303 vol $39.10 each	23,573
Filed 2023-12-18 15:28 Tx date 2023-12-13	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$24,826 +2,303 vol $10.78 each	25,876
Filed 2023-12-18 15:27 Tx date 2023-12-13	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-22,895.36 -577 vol $39.68 each	101,705
Filed 2023-12-18 15:24 Tx date 2023-12-13	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-24,826.34 -2,303 vol $10.78 each	102,282
Filed 2023-12-18 15:19 Tx date 2023-12-13	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-198,594 -5,100 vol $38.94 each	23,573
Filed 2023-12-18 15:12 Tx date 2023-12-13	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$54,978 +5,100 vol $10.78 each	28,673
Filed 2023-12-18 15:06 Tx date 2023-12-13	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-13,776.84 -1,278 vol $10.78 each	104,585
Filed 2023-12-18 14:54 Tx date 2023-12-13	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-54,978 -5,100 vol $10.78 each	105,863
Filed 2023-08-24 16:45 Tx date 2023-08-24	$XENE Xenon Pharmaceuticals Inc.	Svoronos, Dawn 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-967,500 -25,000 vol $38.70 each	25,000
Filed 2023-08-10 19:41 Tx date 2023-08-10	$XENE Xenon Pharmaceuticals Inc.	Gover, Justin 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+28,000 vol	28,000
Filed 2023-08-10 19:39 Tx date 2023-08-08	$XENE Xenon Pharmaceuticals Inc.	Gover, Justin 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2023-08-10 19:30 Tx date 2023-08-10	$XENE Xenon Pharmaceuticals Inc.	Cannon, Gillian 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+28,000 vol	28,000
Filed 2023-08-10 19:28 Tx date 2023-08-08	$XENE Xenon Pharmaceuticals Inc.	Cannon, Gillian 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2023-06-05 13:35 Tx date 2023-06-02	$XENE Xenon Pharmaceuticals Inc.	Garofalo, Elizabeth 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$719,786 +18,475 vol $38.96 each	56,475
Filed 2023-06-05 13:33 Tx date 2023-06-02	$XENE Xenon Pharmaceuticals Inc.	Machado, Patrick 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$719,786 +18,475 vol $38.96 each	66,475
Filed 2023-06-05 13:31 Tx date 2023-06-02	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$719,786 +18,475 vol $38.96 each	106,025
Filed 2023-06-05 13:30 Tx date 2023-06-02	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$719,786 +18,475 vol $38.96 each	1,218,157
Filed 2023-06-05 13:28 Tx date 2023-06-02	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$719,786 +18,475 vol $38.96 each	110,963
Filed 2023-06-05 13:26 Tx date 2023-06-02	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$719,786 +18,475 vol $38.96 each	98,619
Filed 2023-06-05 13:24 Tx date 2023-06-02	$XENE Xenon Pharmaceuticals Inc.	Svoronos, Dawn 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$719,786 +18,475 vol $38.96 each	95,119
Filed 2023-06-02 18:02 Tx date 2023-06-01	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-940,608.90 -24,255 vol $38.78 each	6,000
Filed 2023-06-02 18:01 Tx date 2023-06-01	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-799,304.85 -20,745 vol $38.53 each	30,255
Filed 2023-06-02 17:59 Tx date 2023-06-01	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$799,200 +45,000 vol $17.76 each	51,000
Filed 2023-06-02 17:58 Tx date 2023-06-01	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-799,200 -45,000 vol $17.76 each	1,199,682
Filed 2023-06-02 17:56 Tx date 2023-06-01	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-290,638.26 -7,458 vol $38.97 each	6,000
Filed 2023-06-02 17:55 Tx date 2023-06-01	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-71,665.80 -1,860 vol $38.53 each	13,458
Filed 2023-06-02 17:49 Tx date 2023-06-01	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-71,655.42 -9,318 vol $7.69 each	1,244,682
Filed 2023-06-02 17:46 Tx date 2023-06-01	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$71,655 +9,318 vol $7.69 each	15,318
Filed 2023-06-02 17:45 Tx date 2023-05-31	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,039,058.64 -26,856 vol $38.69 each	6,000
Filed 2023-06-02 17:42 Tx date 2023-05-31	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-888,035.28 -23,144 vol $38.37 each	32,856
Filed 2023-06-02 17:41 Tx date 2023-05-31	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$888,000 +50,000 vol $17.76 each	56,000
Filed 2023-06-02 17:39 Tx date 2023-05-31	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-888,000 -50,000 vol $17.76 each	1,254,000
Filed 2023-06-02 17:34 Tx date 2023-05-31	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-918,632.70 -23,670 vol $38.81 each	6,000
Filed 2023-06-02 17:32 Tx date 2023-05-31	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$-236,551.05 -6,165 vol $38.37 each	29,670
Filed 2023-06-02 17:29 Tx date 2023-05-31	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$293,874 +29,835 vol $9.85 each	35,835
Filed 2023-06-02 17:26 Tx date 2023-05-31	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-293,874.75 -29,835 vol $9.85 each	1,304,000
Filed 2023-06-02 17:13 Tx date 2023-05-31	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-462,360 -12,000 vol $38.53 each	6,000
Filed 2023-06-02 17:11 Tx date 2023-05-30	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-758,100 -19,000 vol $39.90 each	18,000
Filed 2023-06-02 17:09 Tx date 2023-05-30	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-695,571.78 -18,006 vol $38.63 each	37,000
Filed 2023-05-26 19:38 Tx date 2023-05-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-58,376.43 -1,407 vol $41.49 each	31,302
Filed 2023-05-26 19:37 Tx date 2023-05-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-1,171 vol	32,709
Filed 2023-05-26 19:36 Tx date 2023-05-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+6,172 vol	33,880
Filed 2023-05-26 19:35 Tx date 2023-05-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-545,215.23 -13,179 vol $41.37 each	27,708
Filed 2023-05-26 19:35 Tx date 2023-05-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-3,902 vol	40,887
Filed 2023-05-26 19:34 Tx date 2023-05-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+20,576 vol	44,789
Filed 2023-05-26 19:33 Tx date 2023-05-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-707,339.36 -17,069 vol $41.44 each	24,213
Filed 2023-05-26 19:31 Tx date 2023-05-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-7,310 vol	41,282
Filed 2023-05-26 19:30 Tx date 2023-05-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+42,592 vol	48,592
Filed 2023-05-26 19:28 Tx date 2023-05-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-60,794.20 -6,172 vol $9.85 each	1,610,000
Filed 2023-05-26 19:25 Tx date 2023-05-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-202,673.60 -20,576 vol $9.85 each	1,616,172
Filed 2023-05-26 19:19 Tx date 2023-05-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-402,068.48 -42,592 vol $9.44 each	1,636,748
Filed 2023-03-24 19:31 Tx date 2023-03-24	$XENE Xenon Pharmaceuticals Inc.	Kenney, Christopher John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-24,507 -700 vol $35.01 each	0
Filed 2023-03-14 17:16 Tx date 2023-03-10	$XENE Xenon Pharmaceuticals Inc.	DiFabio, Andrea 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+45,000 vol	180,000
Filed 2023-03-14 17:06 Tx date 2023-03-10	$XENE Xenon Pharmaceuticals Inc.	Kenney, Christopher John 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+120,000 vol	395,000
Filed 2023-03-14 17:04 Tx date 2023-03-10	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+120,000 vol	398,334
Filed 2023-03-14 17:01 Tx date 2023-03-10	$XENE Xenon Pharmaceuticals Inc.	Von Seggern, Christopher 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+90,000 vol	350,000
Filed 2023-03-14 16:59 Tx date 2023-03-10	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+75,000 vol	310,000
Filed 2023-03-14 16:57 Tx date 2023-03-10	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+75,000 vol	442,141
Filed 2023-03-14 16:53 Tx date 2023-03-10	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+380,000 vol	1,679,340
Filed 2023-03-09 19:02 Tx date 2023-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-304,459.48 -8,242 vol $36.94 each	55,006
Filed 2023-03-09 19:01 Tx date 2023-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-1,618 vol	63,248
Filed 2023-03-09 19:01 Tx date 2023-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+30,864 vol	64,866
Filed 2023-03-09 19:00 Tx date 2023-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-406,739.90 -10,990 vol $37.01 each	34,002
Filed 2023-03-09 18:59 Tx date 2023-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-2,160 vol	44,992
Filed 2023-03-09 18:58 Tx date 2023-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+41,152 vol	47,152
Filed 2023-03-09 18:55 Tx date 2023-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-79,937.76 -30,864 vol $2.59 each	1,333,835
Filed 2023-03-09 18:54 Tx date 2023-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-110,287.36 -41,152 vol $2.68 each	1,364,699
Filed 2022-12-13 16:36 Tx date 2022-12-12	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$8,239 +3,086 vol $2.67 each	69,905
Filed 2022-12-13 16:35 Tx date 2022-12-12	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-8,239.62 -3,086 vol $2.67 each	87,550
Filed 2022-11-28 20:53 Tx date 2022-11-25	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-67,390.3607 -1,937 vol $34.79 each	23,573
Filed 2022-11-28 20:52 Tx date 2022-11-25	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-120 vol	25,510
Filed 2022-11-28 20:51 Tx date 2022-11-25	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$5,512 +2,057 vol $2.68 each	25,630
Filed 2022-11-28 20:49 Tx date 2022-11-25	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-5,512.76 -2,057 vol $2.68 each	92,488
Filed 2022-11-28 20:46 Tx date 2022-11-23	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-70,609.6105 -2,057 vol $34.33 each	23,573
Filed 2022-11-09 17:19 Tx date 2022-11-07	$XENE Xenon Pharmaceuticals Inc.	DiFabio, Andrea 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+135,000 vol	135,000
Filed 2022-11-09 17:16 Tx date 2022-11-07	$XENE Xenon Pharmaceuticals Inc.	DiFabio, Andrea 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2022-09-07 16:42 Tx date 2022-09-02	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-607,597.35 -15,355 vol $39.57 each	0
Filed 2022-09-07 16:41 Tx date 2022-09-02	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-3,293 vol	15,355
Filed 2022-09-07 16:40 Tx date 2022-09-02	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+6,511 vol	18,648
Filed 2022-09-07 16:40 Tx date 2022-09-02	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+2,292 vol	12,137
Filed 2022-09-07 16:39 Tx date 2022-09-02	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+813 vol	9,845
Filed 2022-09-07 16:38 Tx date 2022-09-02	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+32 vol	9,032
Filed 2022-09-07 16:38 Tx date 2022-09-02	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+9,000 vol	9,000
Filed 2022-09-07 16:37 Tx date 2021-06-03	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2022-09-07 16:35 Tx date 2022-09-02	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-30,927.25 -6,511 vol $4.75 each	278,334
Filed 2022-09-07 16:35 Tx date 2022-09-02	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-7,105.20 -2,292 vol $3.10 each	284,845
Filed 2022-09-07 16:33 Tx date 2022-09-02	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-6,829.20 -813 vol $8.40 each	287,137
Filed 2022-09-07 16:32 Tx date 2022-09-02	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-239.68 -32 vol $7.49 each	287,950
Filed 2022-09-07 16:30 Tx date 2022-09-02	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-84,960 -9,000 vol $9.44 each	287,982
Filed 2022-09-02 17:36 Tx date 2022-09-01	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-340,508.80 -8,776 vol $38.80 each	16,796
Filed 2022-09-02 17:35 Tx date 2022-09-01	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,334,967.09 -35,103 vol $38.03 each	25,572
Filed 2022-09-02 17:34 Tx date 2022-09-01	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-6,121 vol	60,675
Filed 2022-09-02 17:33 Tx date 2022-09-01	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+50,000 vol	66,796
Filed 2022-09-02 17:32 Tx date 2022-08-31	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-823,546.64 -21,352 vol $38.57 each	16,796
Filed 2022-09-02 17:31 Tx date 2022-08-31	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-1,572 vol	38,148
Filed 2022-09-02 17:30 Tx date 2022-08-31	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+5,000 vol	39,720
Filed 2022-09-02 17:29 Tx date 2022-08-31	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+17,488 vol	34,720
Filed 2022-09-02 17:26 Tx date 2022-09-01	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-237,500 -50,000 vol $4.75 each	367,141
Filed 2022-09-02 17:22 Tx date 2022-08-31	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-23,750 -5,000 vol $4.75 each	417,141
Filed 2022-09-02 17:21 Tx date 2022-08-31	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-46,692.96 -17,488 vol $2.67 each	422,141
Filed 2022-08-16 18:06 Tx date 2022-08-12	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-846,125 -21,875 vol $38.68 each	10,000
Filed 2022-08-16 18:06 Tx date 2022-08-12	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,365,853.44 -35,868 vol $38.08 each	31,875
Filed 2022-08-16 18:05 Tx date 2022-08-12	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-7,257 vol	67,743
Filed 2022-08-16 18:03 Tx date 2022-08-12	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+45,000 vol	75,000
Filed 2022-08-16 18:03 Tx date 2022-08-12	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+20,000 vol	30,000
Filed 2022-08-16 18:01 Tx date 2022-08-12	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-213,750 -45,000 vol $4.75 each	235,000
Filed 2022-08-16 18:00 Tx date 2022-08-12	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-62,000 -20,000 vol $3.10 each	280,000
Filed 2022-08-16 17:54 Tx date 2022-08-16	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-777,400 -20,000 vol $38.87 each	6,000
Filed 2022-08-16 17:53 Tx date 2022-08-16	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,227,500.82 -32,058 vol $38.29 each	26,000
Filed 2022-08-16 17:53 Tx date 2022-08-15	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,281,649.92 -33,942 vol $37.76 each	58,058
Filed 2022-08-16 17:52 Tx date 2022-08-12	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-39,150 -1,000 vol $39.15 each	92,000
Filed 2022-08-16 17:51 Tx date 2022-08-12	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,814,200 -47,000 vol $38.60 each	93,000
Filed 2022-08-16 17:50 Tx date 2022-08-12	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-1,635,247.85 -43,135 vol $37.91 each	140,000
Filed 2022-06-29 19:04 Tx date 2022-06-28	$XENE Xenon Pharmaceuticals Inc.	Garofalo, Elizabeth 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$541,980 +18,000 vol $30.11 each	38,000
Filed 2022-06-29 19:02 Tx date 2022-06-28	$XENE Xenon Pharmaceuticals Inc.	Machado, Patrick 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$541,980 +18,000 vol $30.11 each	48,000
Filed 2022-06-29 18:58 Tx date 2022-06-28	$XENE Xenon Pharmaceuticals Inc.	Svoronos, Dawn 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$541,980 +18,000 vol $30.11 each	76,644
Filed 2022-06-29 18:56 Tx date 2022-06-28	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$541,980 +18,000 vol $30.11 each	1,405,851
Filed 2022-06-29 18:53 Tx date 2022-06-28	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$541,980 +18,000 vol $30.11 each	94,545
Filed 2022-06-29 18:45 Tx date 2022-06-28	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$541,980 +18,000 vol $30.11 each	80,144
Filed 2022-06-29 18:42 Tx date 2022-06-28	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$541,980 +18,000 vol $30.11 each	90,636
Filed 2022-05-25 11:42 Tx date 2022-05-02	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Holder: 9465-2138 Québec inc. (Indirect Ownership)	Common Shares 90 - Change in the nature of ownership	+15,000 vol	15,000
Filed 2022-05-25 11:41 Tx date 2015-05-21	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Holder: 9465-2138 Québec inc. (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2022-05-25 10:41 Tx date 2022-05-02	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Direct Ownership	Common Shares 90 - Change in the nature of ownership	-15,000 vol	0
Filed 2022-03-14 17:12 Tx date 2022-03-10	$XENE Xenon Pharmaceuticals Inc.	Kenney, Christopher John 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+125,000 vol	275,000
Filed 2022-03-14 17:11 Tx date 2022-03-10	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+125,000 vol	296,982
Filed 2022-03-14 17:08 Tx date 2022-03-10	$XENE Xenon Pharmaceuticals Inc.	Von Seggern, Christopher 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	260,000
Filed 2022-03-14 16:39 Tx date 2022-03-10	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+65,000 vol	300,000
Filed 2022-03-14 16:36 Tx date 2022-03-10	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+75,000 vol	439,629
Filed 2022-03-14 16:34 Tx date 2022-03-10	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+25,000 vol	1,387,851
Filed 2022-03-14 16:30 Tx date 2022-03-10	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+400,000 vol	1,299,340
Filed 2022-03-08 22:04 Tx date 2022-03-08	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-76,250 -2,500 vol $30.50 each	183,135
Filed 2022-03-08 22:03 Tx date 2022-03-08	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-76,375 -2,500 vol $30.55 each	185,635
Filed 2022-03-08 22:02 Tx date 2022-03-08	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-75,500 -2,500 vol $30.20 each	188,135
Filed 2022-03-08 22:02 Tx date 2022-03-08	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-75,250 -2,500 vol $30.10 each	190,635
Filed 2022-03-08 22:01 Tx date 2022-03-08	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-77,000 -2,500 vol $30.80 each	193,135
Filed 2022-03-08 22:01 Tx date 2022-03-08	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-62,760.60 -2,051 vol $30.60 each	195,635
Filed 2022-03-08 22:00 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-76,375 -2,500 vol $30.55 each	197,686
Filed 2022-03-08 22:00 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-228,750 -7,500 vol $30.50 each	200,186
Filed 2022-03-08 21:59 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-76,300 -2,500 vol $30.52 each	207,686
Filed 2022-03-08 21:59 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-137,467.04 -4,516 vol $30.44 each	210,186
Filed 2022-03-08 21:58 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-137,512.20 -4,516 vol $30.45 each	214,702
Filed 2022-03-08 21:57 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-137,723.33 -4,517 vol $30.49 each	219,218
Filed 2022-03-08 21:57 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-154,132.20 -5,037 vol $30.60 each	223,735
Filed 2022-03-08 21:56 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-1,990 vol	228,772
Filed 2022-03-08 21:55 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$76,954 +20,576 vol $3.74 each	230,762
Filed 2022-03-08 21:55 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-146,474.08 -4,793 vol $30.56 each	210,186
Filed 2022-03-08 21:54 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-138,951.12 -4,532 vol $30.66 each	214,979
Filed 2022-03-08 21:53 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-963 vol	219,511
Filed 2022-03-08 21:53 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$38,477 +10,288 vol $3.74 each	220,474
Filed 2022-03-08 21:52 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-76,954.24 -20,576 vol $3.74 each	1,362,851
Filed 2022-03-08 21:51 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-38,477.12 -10,288 vol $3.74 each	1,383,427
Filed 2022-03-08 20:28 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-948,205.92 -31,048 vol $30.54 each	10,000
Filed 2022-03-08 20:28 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-55,269.10 -1,805 vol $30.62 each	41,048
Filed 2022-03-08 20:27 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-8,952 vol	42,853
Filed 2022-03-08 20:26 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$270,400 +40,000 vol $6.76 each	51,805
Filed 2022-03-08 20:25 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-695 vol	11,805
Filed 2022-03-08 20:24 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$21,000 +2,500 vol $8.40 each	12,500
Filed 2022-03-08 20:23 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-563,918.85 -18,315 vol $30.79 each	10,000
Filed 2022-03-08 20:22 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-6,685 vol	28,315
Filed 2022-03-08 20:21 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+25,000 vol	35,000
Filed 2022-03-08 20:21 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-270,400 -40,000 vol $6.76 each	235,000
Filed 2022-03-08 20:20 Tx date 2022-03-07	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-21,000 -2,500 vol $8.40 each	275,000
Filed 2022-03-08 20:19 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-210,000 -25,000 vol $8.40 each	277,500
Filed 2022-03-08 20:14 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-151,150 -5,000 vol $30.23 each	17,232
Filed 2022-03-08 20:13 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-155,250 -5,000 vol $31.05 each	22,232
Filed 2022-03-08 20:12 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-150,750 -5,000 vol $30.15 each	27,232
Filed 2022-03-08 20:11 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-205,057.60 -6,710 vol $30.56 each	32,232
Filed 2022-03-08 20:10 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	+6,172 vol	38,942
Filed 2022-03-08 20:09 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-696 vol	32,770
Filed 2022-03-08 20:07 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$4,615 +1,234 vol $3.74 each	33,466
Filed 2022-03-08 20:05 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-23,083.28 -6,172 vol $3.74 each	364,629
Filed 2022-03-08 20:05 Tx date 2022-03-04	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-4,615.16 -1,234 vol $3.74 each	370,801
Filed 2022-01-21 17:09 Tx date 2022-01-21	$XENE Xenon Pharmaceuticals Inc.	Kenney, Christopher John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$20,167 +700 vol $28.81 each	700
Filed 2022-01-21 17:07 Tx date 2021-08-23	$XENE Xenon Pharmaceuticals Inc.	Kenney, Christopher John 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2021-12-17 16:17 Tx date 2021-12-15	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$11,541 +3,086 vol $3.74 each	66,819
Filed 2021-12-17 16:16 Tx date 2021-12-15	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-11,541.64 -3,086 vol $3.74 each	72,636
Filed 2021-12-10 16:39 Tx date 2021-12-08	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$7,693 +2,057 vol $3.74 each	25,630
Filed 2021-12-10 16:36 Tx date 2021-12-08	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-7,693.18 -2,057 vol $3.74 each	76,545
Filed 2021-12-07 16:32 Tx date 2021-12-06	$XENE Xenon Pharmaceuticals Inc.	Von Seggern, Christopher 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$97,600 +4,000 vol $24.40 each	4,000
Filed 2021-12-07 16:22 Tx date 2020-08-17	$XENE Xenon Pharmaceuticals Inc.	Von Seggern, Christopher 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2021-11-16 20:58 Tx date 2021-11-15	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-550,060.81 -17,557 vol $31.33 each	210,186
Filed 2021-08-25 16:22 Tx date 2021-08-23	$XENE Xenon Pharmaceuticals Inc.	Kenney, Christopher John 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+150,000 vol	150,000
Filed 2021-08-25 16:20 Tx date 2021-08-23	$XENE Xenon Pharmaceuticals Inc.	Kenney, Christopher John 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2021-06-09 19:31 Tx date 2021-05-31	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Holder: David Patou (Indirect Ownership)	Common Shares 90 - Change in the nature of ownership	-100 vol	0
Filed 2021-06-09 13:51 Tx date 2021-03-17	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Holder: David Patou (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$1,948 +100 vol $19.49 each	100
Filed 2021-06-09 13:43 Tx date 2014-11-05	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Holder: David Patou (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2021-06-04 19:55 Tx date 2021-06-03	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$185,600 +10,000 vol $18.56 each	78,602
Filed 2021-06-03 21:57 Tx date 2021-06-03	$XENE Xenon Pharmaceuticals Inc.	Svoronos, Dawn 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$185,600 +10,000 vol $18.56 each	58,644
Filed 2021-06-03 21:55 Tx date 2021-06-03	$XENE Xenon Pharmaceuticals Inc.	Machado, Patrick 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$185,600 +10,000 vol $18.56 each	30,000
Filed 2021-06-03 21:52 Tx date 2021-06-03	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$185,600 +10,000 vol $18.56 each	65,844
Filed 2021-06-03 21:50 Tx date 2021-06-03	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$185,600 +10,000 vol $18.56 each	62,144
Filed 2021-06-03 21:40 Tx date 2021-06-03	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$185,600 +10,000 vol $18.56 each	75,722
Filed 2021-06-03 21:37 Tx date 2021-06-03	$XENE Xenon Pharmaceuticals Inc.	Garofalo, Elizabeth 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+20,000 vol	20,000
Filed 2021-06-03 21:35 Tx date 2021-06-03	$XENE Xenon Pharmaceuticals Inc.	Garofalo, Elizabeth 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2021-06-03 18:46 Tx date 2021-06-03	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$2,320,000 +125,000 vol $18.56 each	899,340
Filed 2021-06-03 18:42 Tx date 2021-06-03	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,855,999 +100,000 vol $18.56 each	171,982
Filed 2021-06-03 18:40 Tx date 2021-06-03	$XENE Xenon Pharmaceuticals Inc.	Aulin, Sherry 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report		71,982
Filed 2021-06-01 18:03 Tx date 2021-05-28	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-54,774.72 -2,912 vol $18.81 each	32,232
Filed 2021-06-01 18:01 Tx date 2021-05-28	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-59,345.55 -3,155 vol $18.81 each	35,144
Filed 2021-06-01 18:00 Tx date 2021-05-28	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-2,192 vol	38,299
Filed 2021-06-01 18:00 Tx date 2021-05-28	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$50,018 +13,374 vol $3.74 each	40,491
Filed 2021-06-01 17:59 Tx date 2021-05-28	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-2,024 vol	27,117
Filed 2021-06-01 17:59 Tx date 2021-05-28	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$46,170 +12,345 vol $3.74 each	29,141
Filed 2021-06-01 17:58 Tx date 2021-05-28	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-50,018.76 -13,374 vol $3.74 each	372,035
Filed 2021-06-01 17:57 Tx date 2021-05-28	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-46,170.30 -12,345 vol $3.74 each	385,409
Filed 2021-06-01 17:47 Tx date 2021-05-27	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-158,499.80 -8,485 vol $18.68 each	143,653
Filed 2021-06-01 17:46 Tx date 2021-05-27	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-48,201.51 -2,579 vol $18.69 each	152,138
Filed 2021-06-01 17:44 Tx date 2021-05-27	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-5,911 vol	154,717
Filed 2021-06-01 17:43 Tx date 2021-05-27	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$134,669 +36,008 vol $3.74 each	160,628
Filed 2021-06-01 17:42 Tx date 2021-05-27	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-507 vol	124,620
Filed 2021-06-01 17:42 Tx date 2021-05-27	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$11,541 +3,086 vol $3.74 each	125,127
Filed 2021-06-01 17:41 Tx date 2021-05-27	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-134,669.92 -36,008 vol $3.74 each	75,187
Filed 2021-06-01 17:39 Tx date 2021-05-27	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-11,541.64 -3,086 vol $3.74 each	111,195
Filed 2021-05-26 16:25 Tx date 2021-05-24	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-5,076 vol	227,743
Filed 2021-05-26 16:23 Tx date 2021-05-24	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$84,647 +22,633 vol $3.74 each	232,819
Filed 2021-05-26 16:22 Tx date 2021-05-24	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-84,647.42 -22,633 vol $3.74 each	1,393,715
Filed 2021-05-20 21:07 Tx date 2021-05-18	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$18,878 +5,144 vol $3.67 each	77,942
Filed 2021-05-20 21:06 Tx date 2021-05-18	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-18,878.48 -5,144 vol $3.67 each	80,771
Filed 2021-05-20 21:05 Tx date 2021-05-18	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$3,772 +1,028 vol $3.67 each	72,798
Filed 2021-05-20 21:04 Tx date 2021-05-18	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-3,772.76 -1,028 vol $3.67 each	85,915
Filed 2021-05-20 21:03 Tx date 2021-05-18	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$7,960 +2,057 vol $3.87 each	71,770
Filed 2021-05-20 21:02 Tx date 2021-05-18	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-7,960.59 -2,057 vol $3.87 each	86,943
Filed 2021-05-20 20:53 Tx date 2021-05-18	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$13,475 +3,500 vol $3.85 each	116,206
Filed 2021-05-20 20:50 Tx date 2021-05-18	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-13,475 -3,500 vol $3.85 each	55,844
Filed 2021-03-15 17:10 Tx date 2021-03-12	$XENE Xenon Pharmaceuticals Inc.	Von Seggern, Christopher 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+60,000 vol	160,000
Filed 2021-03-15 17:06 Tx date 2021-03-12	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	774,340
Filed 2021-03-15 17:02 Tx date 2021-03-12	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+65,000 vol	302,500
Filed 2021-03-15 16:58 Tx date 2021-03-12	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+225,000 vol	1,416,348
Filed 2021-03-15 16:52 Tx date 2021-03-12	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+65,000 vol	397,754
Filed 2021-02-18 20:59 Tx date 2021-02-18	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Genworks Inc. (Indirect Ownership)	Common Shares 51 - Exercise of options	$82,406 +30,864 vol $2.67 each	92,076
Filed 2021-02-18 20:58 Tx date 2021-02-18	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Genworks Inc. (Indirect Ownership)	Options 51 - Exercise of options	-30,864 vol	0
Filed 2021-02-18 20:56 Tx date 2021-02-18	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Genworks Inc. (Indirect Ownership)	Common Shares 51 - Exercise of options	$38,477 +10,288 vol $3.74 each	61,212
Filed 2021-02-18 20:54 Tx date 2021-02-18	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Genworks Inc. (Indirect Ownership)	Options 51 - Exercise of options	-10,288 vol	30,864
Filed 2021-02-18 20:49 Tx date 2021-02-16	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$13,734 +5,144 vol $2.67 each	112,706
Filed 2021-02-18 20:47 Tx date 2021-02-16	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-13,734.48 -5,144 vol $2.67 each	59,344
Filed 2020-12-15 16:49 Tx date 2020-12-15	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$11,541 +3,086 vol $3.74 each	63,733
Filed 2020-12-15 16:48 Tx date 2020-12-15	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-11,541.64 -3,086 vol $3.74 each	65,722
Filed 2020-11-05 20:39 Tx date 2020-11-05	$XENE Xenon Pharmaceuticals Inc.	Machado, Patrick 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+20,000 vol	20,000
Filed 2020-11-05 20:34 Tx date 2020-11-05	$XENE Xenon Pharmaceuticals Inc.	Machado, Patrick 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2020-10-29 17:06 Tx date 2020-10-28	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 47 - Acquisition or disposition by gift	$-38,477.12 -10,288 vol $3.74 each	69,713
Filed 2020-10-29 16:57 Tx date 2020-10-28	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$19,238 +5,144 vol $3.74 each	80,001
Filed 2020-10-29 16:56 Tx date 2020-10-28	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-19,238.56 -5,144 vol $3.74 each	89,000
Filed 2020-10-29 16:55 Tx date 2020-10-28	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$19,238 +5,144 vol $3.74 each	74,857
Filed 2020-10-29 16:54 Tx date 2020-10-28	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-19,238.56 -5,144 vol $3.74 each	94,144
Filed 2020-10-29 16:48 Tx date 2020-10-28	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$7,693 +2,057 vol $3.74 each	23,573
Filed 2020-10-29 16:46 Tx date 2020-10-28	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-7,693.18 -2,057 vol $3.74 each	68,602
Filed 2020-08-25 20:20 Tx date 2020-08-20	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Holder: Kanya Adam (Indirect Ownership)	Common Shares 97 - Other	-16,460 vol	0
Filed 2020-08-24 18:47 Tx date 2020-08-20	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 11 - Acquisition or disposition carried out privately	-45,000 vol	210,186
Filed 2020-08-17 19:39 Tx date 2020-08-17	$XENE Xenon Pharmaceuticals Inc.	Von Seggern, Christopher 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+100,000 vol	100,000
Filed 2020-08-17 19:35 Tx date 2020-08-17	$XENE Xenon Pharmaceuticals Inc.	Von Seggern, Christopher 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2020-06-10 18:58 Tx date 2020-06-09	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$19,238 +5,144 vol $3.74 each	69,713
Filed 2020-06-10 18:57 Tx date 2020-06-09	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-19,238.56 -5,144 vol $3.74 each	99,288
Filed 2020-06-02 20:38 Tx date 2020-06-01	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-1,630 vol	16,796
Filed 2020-06-02 20:37 Tx date 2020-06-01	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$30,780 +8,230 vol $3.74 each	18,426
Filed 2020-06-02 20:35 Tx date 2020-06-01	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-30,780.20 -8,230 vol $3.74 each	332,754
Filed 2020-06-02 20:28 Tx date 2020-06-01	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$131,100 +10,000 vol $13.11 each	114,281
Filed 2020-06-02 20:24 Tx date 2020-05-29	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$11,541 +3,086 vol $3.74 each	122,041
Filed 2020-06-02 20:23 Tx date 2020-05-29	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-11,541.64 -3,086 vol $3.74 each	104,281
Filed 2020-06-02 20:07 Tx date 2020-06-01	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$131,100 +10,000 vol $13.11 each	104,432
Filed 2020-06-02 20:05 Tx date 2020-06-01	$XENE Xenon Pharmaceuticals Inc.	Svoronos, Dawn 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$131,100 +10,000 vol $13.11 each	48,644
Filed 2020-06-02 20:03 Tx date 2020-06-01	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$131,100 +10,000 vol $13.11 each	70,659
Filed 2020-06-02 19:59 Tx date 2020-06-01	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$131,100 +10,000 vol $13.11 each	64,488
Filed 2020-06-02 19:51 Tx date 2020-06-01	$XENE Xenon Pharmaceuticals Inc.	Desjardins, Clarissa 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$131,100 +10,000 vol $13.11 each	35,000
Filed 2020-06-02 19:48 Tx date 2020-06-01	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$131,100 +10,000 vol $13.11 each	52,144
Filed 2020-06-02 19:41 Tx date 2020-06-01	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$131,100 +10,000 vol $13.11 each	68,808
Filed 2020-06-02 19:26 Tx date 2020-06-01	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-43,290 -3,000 vol $14.43 each	255,186
Filed 2020-06-02 19:24 Tx date 2020-05-29	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-69,950 -5,000 vol $13.99 each	258,186
Filed 2020-05-28 20:30 Tx date 2020-05-26	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-1,108 vol	263,186
Filed 2020-05-28 20:28 Tx date 2020-05-26	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$23,083 +6,172 vol $3.74 each	264,294
Filed 2020-05-28 20:26 Tx date 2020-05-26	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-23,083.28 -6,172 vol $3.74 each	1,191,348
Filed 2020-03-16 16:49 Tx date 2020-03-12	$XENE Xenon Pharmaceuticals Inc.	Aycardi-Fonseca, Ernesto 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+65,000 vol	180,000
Filed 2020-03-16 16:43 Tx date 2020-03-12	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+65,000 vol	237,500
Filed 2020-03-16 16:37 Tx date 2020-03-12	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+280,000 vol	1,197,520
Filed 2020-03-16 16:33 Tx date 2020-03-12	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+145,000 vol	674,340
Filed 2020-03-16 16:26 Tx date 2020-03-12	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+65,000 vol	340,984
Filed 2020-01-14 15:11 Tx date 2020-01-13	$XENE Xenon Pharmaceuticals Inc.	Desjardins, Clarissa 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+25,000 vol	25,000
Filed 2020-01-14 15:07 Tx date 2020-01-13	$XENE Xenon Pharmaceuticals Inc.	Desjardins, Clarissa 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2019-12-17 17:22 Tx date 2019-12-16	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-11,541.64 -3,086 vol $3.74 each	58,808
Filed 2019-12-17 17:19 Tx date 2019-12-16	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$11,541 +3,086 vol $3.74 each	60,647
Filed 2019-12-06 17:25 Tx date 2019-12-04	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-7,693.18 -2,057 vol $3.74 each	60,659
Filed 2019-12-06 17:23 Tx date 2019-12-04	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$7,693 +2,057 vol $3.74 each	21,516
Filed 2019-11-22 16:20 Tx date 2019-11-21	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-7,693.18 -2,057 vol $3.74 each	94,432
Filed 2019-11-22 16:17 Tx date 2019-11-21	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 47 - Acquisition or disposition by gift	$-7,693.18 -2,057 vol $3.74 each	64,569
Filed 2019-11-22 16:16 Tx date 2019-11-21	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$7,693 +2,057 vol $3.74 each	66,626
Filed 2019-11-22 16:12 Tx date 2019-11-21	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-19,238.56 -5,144 vol $3.74 each	96,489
Filed 2019-11-22 16:10 Tx date 2019-11-21	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 47 - Acquisition or disposition by gift	$-19,238.56 -5,144 vol $3.74 each	64,569
Filed 2019-11-22 16:08 Tx date 2019-11-21	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$19,238 +5,144 vol $3.74 each	69,713
Filed 2019-09-24 18:26 Tx date 2019-09-20	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-98,856.45 -10,395 vol $9.51 each	258,122
Filed 2019-09-20 16:24 Tx date 2019-09-20	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-48,884.34 -5,206 vol $9.39 each	118,955
Filed 2019-09-20 16:23 Tx date 2019-09-19	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-70,452 -7,600 vol $9.27 each	124,161
Filed 2019-09-20 13:02 Tx date 2019-09-16	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$424,800 +45,000 vol $9.44 each	275,984
Filed 2019-09-19 20:21 Tx date 2019-09-18	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-40,535.04 -4,368 vol $9.28 each	131,761
Filed 2019-09-19 20:20 Tx date 2019-09-17	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-47,243.08 -5,069 vol $9.32 each	136,129
Filed 2019-09-19 20:18 Tx date 2019-09-16	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$141,600 +15,000 vol $9.44 each	107,367
Filed 2019-09-19 19:38 Tx date 2019-09-16	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$2,643,200 +280,000 vol $9.44 each	975,132
Filed 2019-09-19 19:35 Tx date 2019-09-17	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$32,362 +8,653 vol $3.74 each	268,517
Filed 2019-09-19 19:34 Tx date 2019-09-17	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-3,692 vol	917,520
Filed 2019-09-19 19:33 Tx date 2019-09-17	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-32,362.22 -8,653 vol $3.74 each	921,212
Filed 2019-09-19 19:32 Tx date 2019-09-17	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$24,272 +6,490 vol $3.74 each	259,864
Filed 2019-09-19 19:31 Tx date 2019-09-17	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-2,769 vol	929,865
Filed 2019-09-19 19:30 Tx date 2019-09-17	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-24,272.60 -6,490 vol $3.74 each	932,634
Filed 2019-09-19 19:29 Tx date 2019-09-17	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$94,393 +25,239 vol $3.74 each	253,374
Filed 2019-09-19 19:27 Tx date 2019-09-17	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-10,769 vol	939,124
Filed 2019-09-19 19:26 Tx date 2019-09-17	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-94,393.86 -25,239 vol $3.74 each	949,893
Filed 2019-09-19 17:24 Tx date 2019-09-12	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$67,091 +17,939 vol $3.74 each	141,198
Filed 2019-09-19 17:23 Tx date 2019-09-12	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-7,781 vol	92,367
Filed 2019-09-19 17:22 Tx date 2019-09-12	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-67,091.86 -17,939 vol $3.74 each	100,148
Filed 2019-09-19 17:21 Tx date 2019-09-12	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$8,048 +2,152 vol $3.74 each	123,259
Filed 2019-09-19 17:19 Tx date 2019-09-12	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-934 vol	118,087
Filed 2019-09-19 17:18 Tx date 2019-09-12	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-8,048.48 -2,152 vol $3.74 each	119,021
Filed 2019-09-19 17:16 Tx date 2019-09-12	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$8,048 +2,152 vol $3.74 each	121,107
Filed 2019-09-19 17:15 Tx date 2019-09-12	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-934 vol	121,173
Filed 2019-09-19 17:13 Tx date 2019-09-12	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-8,048.48 -2,152 vol $3.74 each	122,107
Filed 2019-09-19 15:56 Tx date 2019-09-16	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$141,600 +15,000 vol $9.44 each	42,144
Filed 2019-09-19 15:22 Tx date 2019-09-16	$XENE Xenon Pharmaceuticals Inc.	Aycardi-Fonseca, Ernesto 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$613,600 +65,000 vol $9.44 each	115,000
Filed 2019-09-19 15:17 Tx date 2019-09-16	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$377,600 +40,000 vol $9.44 each	172,500
Filed 2019-09-19 15:13 Tx date 2019-09-16	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,274,400 +135,000 vol $9.44 each	529,340
Filed 2019-09-19 15:07 Tx date 2019-09-16	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$141,600 +15,000 vol $9.44 each	54,488
Filed 2019-09-19 14:50 Tx date 2019-09-16	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$141,600 +15,000 vol $9.44 each	62,716
Filed 2019-09-19 14:34 Tx date 2019-09-16	$XENE Xenon Pharmaceuticals Inc.	Scheller, Richard Henry 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$141,600 +15,000 vol $9.44 each	45,230
Filed 2019-09-19 14:17 Tx date 2019-09-16	$XENE Xenon Pharmaceuticals Inc.	Svoronos, Dawn 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$141,600 +15,000 vol $9.44 each	38,644
Filed 2019-09-19 14:05 Tx date 2019-09-16	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$141,600 +15,000 vol $9.44 each	101,633
Filed 2019-09-18 21:29 Tx date 2019-09-13	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-214.1806 -23 vol $9.31 each	57,561
Filed 2019-09-18 21:24 Tx date 2019-09-16	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$141,600 +15,000 vol $9.44 each	61,894
Filed 2019-09-18 21:07 Tx date 2019-09-13	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-214.1806 -23 vol $9.31 each
Filed 2019-09-18 20:24 Tx date 2019-09-12	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$16,096 +4,304 vol $3.74 each	10,196
Filed 2019-09-18 20:17 Tx date 2019-09-12	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-1,868 vol	230,984
Filed 2019-09-18 20:15 Tx date 2019-09-12	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-16,096.96 -4,304 vol $3.74 each	232,852
Filed 2019-05-22 20:34 Tx date 2019-05-21	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-7,693.18 -2,057 vol $3.74 each	86,633
Filed 2019-05-22 20:31 Tx date 2019-05-21	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$7,693 +2,057 vol $3.74 each	64,569
Filed 2019-03-20 Tx date 2019-03-19	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Genworks Inc. (Indirect Ownership)	Common Shares 51 - Exercise of options	$76,954 +20,576 vol $3.74 each	50,924
Filed 2019-03-20 Tx date 2019-03-19	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Genworks Inc. (Indirect Ownership)	Options 51 - Exercise of options	-20,576 vol	41,152
Filed 2019-03-14 Tx date 2019-03-11	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Common Shares 47 - Acquisition or disposition by gift	-24,045 vol
Filed 2019-03-14 Tx date 2019-03-11	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Sandra Hayden (Indirect Ownership)	Common Shares 47 - Acquisition or disposition by gift	+17,337 vol	114,403
Filed 2019-03-14 Tx date 2019-03-11	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Common Shares 47 - Acquisition or disposition by gift	-24,045 vol	107,562
Filed 2018-12-26 Tx date 2018-12-21	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 47 - Acquisition or disposition by gift	-5,000 vol	62,512
Filed 2018-12-18 Tx date 2018-12-14	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-7,693.18 -2,057 vol $3.74 each	47,716
Filed 2018-12-18 Tx date 2018-12-14	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$7,693 +2,057 vol $3.74 each	19,459
Filed 2018-12-13 Tx date 2018-12-11	$XENE Xenon Pharmaceuticals Inc.	Cohen, Charles Jay 5 - Senior Officer of Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-1,644 vol	6,550
Filed 2018-12-13 Tx date 2018-12-11	$XENE Xenon Pharmaceuticals Inc.	Cohen, Charles Jay 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$15,390 +4,115 vol $3.74 each	8,194
Filed 2018-12-13 Tx date 2018-12-11	$XENE Xenon Pharmaceuticals Inc.	Cohen, Charles Jay 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-15,390.10 -4,115 vol $3.74 each	160,915
Filed 2018-12-10 Tx date 2018-12-06	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$11,541 +3,086 vol $3.74 each	57,584
Filed 2018-12-10 Tx date 2018-12-06	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-11,541.64 -3,086 vol $3.74 each	46,894
Filed 2018-06-22 Tx date 2018-06-21	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-10,288 vol	49,980
Filed 2018-06-22 Tx date 2018-06-21	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-5,144 vol	88,690
Filed 2018-06-22 Tx date 2018-06-21	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-2,057 vol	93,834
Filed 2018-06-22 Tx date 2018-06-21	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-5,144 vol	95,891
Filed 2018-06-22 Tx date 2018-06-21	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$46,170 +12,345 vol $3.74 each	67,512
Filed 2018-06-22 Tx date 2018-06-21	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$38,477 +10,288 vol $3.74 each	54,498
Filed 2018-06-15 Tx date 2018-06-14	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-2,856 vol	49,773
Filed 2018-06-15 Tx date 2018-06-14	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$20,098 +5,374 vol $3.74 each	17,402
Filed 2018-06-15 Tx date 2018-06-14	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-5,374 vol	52,629
Filed 2018-06-05 Tx date 2018-06-04	$XENE Xenon Pharmaceuticals Inc.	Scheller, Richard Henry 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$93,000 +15,000 vol $6.20 each	30,230
Filed 2018-06-05 Tx date 2018-06-04	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$93,000 +15,000 vol $6.20 each	60,268
Filed 2018-06-05 Tx date 2018-06-04	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$93,000 +15,000 vol $6.20 each	27,144
Filed 2018-06-05 Tx date 2018-06-04	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$93,000 +15,000 vol $6.20 each	39,488
Filed 2018-06-05 Tx date 2018-06-04	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$93,000 +15,000 vol $6.20 each	124,259
Filed 2018-06-05 Tx date 2018-06-04	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$93,000 +15,000 vol $6.20 each	58,003
Filed 2018-06-05 Tx date 2018-06-04	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$93,000 +15,000 vol $6.20 each	101,035
Filed 2018-06-05 Tx date 2018-06-04	$XENE Xenon Pharmaceuticals Inc.	Svoronos, Dawn 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$93,000 +15,000 vol $6.20 each	23,644
Filed 2018-03-20 Tx date 2018-03-19	$XENE Xenon Pharmaceuticals Inc.	Aycardi-Fonseca, Ernesto 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	50,000
Filed 2018-03-20 Tx date 2018-03-19	$XENE Xenon Pharmaceuticals Inc.	Aycardi-Fonseca, Ernesto 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2018-03-20 Tx date 2018-03-19	$XENE Xenon Pharmaceuticals Inc.	Aycardi-Fonseca, Ernesto 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16 Tx date 2018-03-14	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$11,541 +3,086 vol $3.74 each	118,955
Filed 2018-03-16 Tx date 2018-03-14	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-11,541.64 -3,086 vol $3.74 each	109,259
Filed 2018-03-16 Tx date 2018-03-15	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-1,928 vol	237,156
Filed 2018-03-16 Tx date 2018-03-15	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$4,330 +1,158 vol $3.74 each	5,892
Filed 2018-03-16 Tx date 2018-03-15	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-4,330.92 -1,158 vol $3.74 each	239,084
Filed 2018-03-14 Tx date 2018-03-12	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$38,477 +10,288 vol $3.74 each	228,135
Filed 2018-03-14 Tx date 2018-03-12	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-38,477.12 -10,288 vol $3.74 each	695,132
Filed 2018-03-13 Tx date 2018-03-12	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+45,000 vol	132,500
Filed 2018-03-13 Tx date 2018-03-12	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+140,000 vol	705,420
Filed 2018-03-13 Tx date 2018-03-12	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+55,000 vol	240,242
Filed 2018-03-13 Tx date 2018-03-12	$XENE Xenon Pharmaceuticals Inc.	Cohen, Charles Jay 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+40,000 vol	165,030
Filed 2018-03-13 Tx date 2018-03-12	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+105,000 vol	394,340
Filed 2018-03-01 Tx date 2018-02-22	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Common Shares 47 - Acquisition or disposition by gift	-29,580 vol	131,607
Filed 2018-03-01 Tx date 2018-02-22	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Sandra Hayden (Indirect Ownership)	Common Shares 47 - Acquisition or disposition by gift	+21,180 vol	97,066
Filed 2018-02-14 Tx date 2018-02-12	$XENE Xenon Pharmaceuticals Inc.	Cohen, Charles Jay 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$15,255 +4,079 vol $3.74 each	4,079
Filed 2018-02-14 Tx date 2018-02-12	$XENE Xenon Pharmaceuticals Inc.	Cohen, Charles Jay 5 - Senior Officer of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-22,669 vol	129,109
Filed 2018-02-14 Tx date 2018-02-12	$XENE Xenon Pharmaceuticals Inc.	Cohen, Charles Jay 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-4,079 vol	125,030
Filed 2018-02-14 Tx date 2014-11-05	$XENE Xenon Pharmaceuticals Inc.	Cohen, Charles Jay 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2018-01-26 Tx date 2017-08-14	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 52 - Expiration of options	-12,345 vol	112,345
Filed 2018-01-04 Tx date 2018-01-01	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 52 - Expiration of options	-3,497 vol	43,003
Filed 2018-01-04 Tx date 2018-01-01	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 52 - Expiration of options	-6,583 vol	86,035
Filed 2018-01-04 Tx date 2018-01-01	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 52 - Expiration of options	-3,497 vol	45,268
Filed 2017-11-16 Tx date 2017-11-15	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$33,280 +15,000 vol $2.22 each	44,210
Filed 2017-10-24 Tx date 2017-10-23	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+11,000 vol	185,242
Filed 2017-10-24 Tx date 2017-10-23	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+11,000 vol	565,420
Filed 2017-10-24 Tx date 2017-10-23	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+25,000 vol	289,340
Filed 2017-10-24 Tx date 2017-10-23	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+11,000 vol	159,585
Filed 2017-10-24 Tx date 2017-10-23	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+20,000 vol	87,500
Filed 2017-10-24 Tx date 2017-10-23	$XENE Xenon Pharmaceuticals Inc.	Cohen, Charles Jay 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+11,000 vol	151,778
Filed 2017-09-25 Tx date 2017-09-22	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$23,600 +8,000 vol $2.95 each	29,210
Filed 2017-09-25 Tx date 2017-09-21	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$5,900 +2,000 vol $2.95 each	21,210
Filed 2017-08-21 Tx date 2017-08-18	$XENE Xenon Pharmaceuticals Inc.	Winquist, Raymond 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$2,995 +1,000 vol $3.00 each	1,000
Filed 2017-08-21 Tx date 2017-08-17	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$60.95 +23 vol $2.65 each	12,898
Filed 2017-08-21 Tx date 2017-08-18	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$18,301 +6,312 vol $2.90 each	19,210
Filed 2017-08-21 Tx date 2016-04-04	$XENE Xenon Pharmaceuticals Inc.	Winquist, Raymond 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-08-17 Tx date 2016-02-08	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-08-17 Tx date 2017-08-15	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$24,824 +10,000 vol $2.48 each	10,000
Filed 2017-08-15 Tx date 2017-08-14	$XENE Xenon Pharmaceuticals Inc.	Svoronos, Dawn 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$140,770 +50,000 vol $2.82 each	50,000
Filed 2017-08-15 Tx date 2016-09-27	$XENE Xenon Pharmaceuticals Inc.	Svoronos, Dawn 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-08-14 Tx date 2017-08-14	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$41,247 +15,000 vol $2.75 each	161,187
Filed 2017-08-14 Tx date 2015-05-21	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-08-14 Tx date 2017-08-10	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$20,835 +7,500 vol $2.78 each	12,500
Filed 2017-08-14 Tx date 2017-08-10	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$17,400 +6,000 vol $2.90 each	217,847
Filed 2017-08-14 Tx date 2015-03-16	$XENE Xenon Pharmaceuticals Inc.	Scheller, Richard Henry 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-08-14 Tx date 2017-08-10	$XENE Xenon Pharmaceuticals Inc.	Scheller, Richard Henry 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$19,950 +7,000 vol $2.85 each	7,000
Filed 2017-08-14 Tx date 2017-08-11	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$42,267 +15,000 vol $2.82 each	15,000
Filed 2017-08-14 Tx date 2017-08-10	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$14,225 +5,000 vol $2.85 each	6,000
Filed 2017-08-14 Tx date 2017-08-10	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Holder: Katie Mortimer (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$29,000 +10,000 vol $2.90 each	14,300
Filed 2017-08-10 Tx date 2014-11-05	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-08-10 Tx date 2017-08-08	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Holder: Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$15,002 +5,000 vol $3.00 each	5,000
Filed 2017-06-20 Tx date 2017-06-19	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$3,844 +1,028 vol $3.74 each	56,195
Filed 2017-06-20 Tx date 2017-06-19	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 47 - Acquisition or disposition by gift	$-3,844.72 -1,028 vol $3.74 each	55,167
Filed 2017-06-20 Tx date 2017-06-19	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-3,844.72 -1,028 vol $3.74 each	92,618
Filed 2017-06-02 Tx date 2017-06-01	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$13,475 +3,500 vol $3.85 each	46,500
Filed 2017-06-02 Tx date 2017-06-01	$XENE Xenon Pharmaceuticals Inc.	Svoronos, Dawn 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$13,475 +3,500 vol $3.85 each	8,644
Filed 2017-06-02 Tx date 2017-06-01	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$13,475 +3,500 vol $3.85 each	92,396
Filed 2017-06-02 Tx date 2017-06-01	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$4,812 +1,250 vol $3.85 each	93,646
Filed 2017-06-02 Tx date 2017-06-01	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$13,475 +3,500 vol $3.85 each	24,488
Filed 2017-06-02 Tx date 2017-06-01	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$13,475 +3,500 vol $3.85 each	124,690
Filed 2017-06-02 Tx date 2017-06-01	$XENE Xenon Pharmaceuticals Inc.	Scheller, Richard Henry 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$13,475 +3,500 vol $3.85 each	15,230
Filed 2017-06-02 Tx date 2017-06-01	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$13,475 +3,500 vol $3.85 each	48,765
Filed 2017-06-02 Tx date 2017-06-01	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$13,475 +3,500 vol $3.85 each	12,144
Filed 2017-05-16 Tx date 2017-05-12	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 38 - Redemption, retraction, cancellation, repurchase	-1,345 vol	174,242
Filed 2017-05-16 Tx date 2017-05-12	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-2,662.88 -712 vol $3.74 each	175,587
Filed 2017-05-16 Tx date 2017-05-12	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$2,662 +712 vol $3.74 each	4,734
Filed 2017-03-15 Tx date 2017-03-14	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-18,004 vol	51,852
Filed 2017-03-15 Tx date 2017-03-14	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Genworks Inc. (Indirect Ownership)	Options 51 - Exercise of options	-3,086 vol	61,728
Filed 2017-03-15 Tx date 2017-03-14	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Genworks Inc. (Indirect Ownership)	Options 51 - Exercise of options	-4,629 vol	64,814
Filed 2017-03-15 Tx date 2017-03-14	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Genworks Inc. (Indirect Ownership)	Options 51 - Exercise of options	-4,115 vol	69,443
Filed 2017-03-15 Tx date 2017-03-14	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-5,144 vol	20,988
Filed 2017-03-15 Tx date 2017-03-14	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-25,720 vol	26,132
Filed 2017-03-15 Tx date 2017-03-14	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Genworks Inc. (Indirect Ownership)	Common Shares 51 - Exercise of options	$11,541 +3,086 vol $3.74 each	30,348
Filed 2017-03-15 Tx date 2017-03-14	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Genworks Inc. (Indirect Ownership)	Common Shares 51 - Exercise of options	$17,312 +4,629 vol $3.74 each	27,262
Filed 2017-03-15 Tx date 2017-03-14	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Genworks Inc. (Indirect Ownership)	Common Shares 51 - Exercise of options	$15,390 +4,115 vol $3.74 each	22,633
Filed 2017-03-15 Tx date 2017-03-14	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$19,238 +5,144 vol $3.74 each	146,187
Filed 2017-03-15 Tx date 2017-03-14	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$96,192 +25,720 vol $3.74 each	141,043
Filed 2017-03-15 Tx date 2017-03-14	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$67,334 +18,004 vol $3.74 each	115,323
Filed 2017-03-14 Tx date 2017-03-13	$XENE Xenon Pharmaceuticals Inc.	Cohen, Charles Jay 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+20,000 vol	140,778
Filed 2017-03-14 Tx date 2017-03-13	$XENE Xenon Pharmaceuticals Inc.	Winquist, Raymond 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+20,000 vol	55,000
Filed 2017-03-14 Tx date 2017-03-13	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+27,500 vol	176,299
Filed 2017-03-14 Tx date 2017-03-13	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+140,000 vol	554,420
Filed 2017-03-14 Tx date 2017-03-13	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+75,000 vol	264,340
Filed 2017-03-14 Tx date 2017-03-13	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+27,500 vol	148,585
Filed 2017-03-14 Tx date 2017-03-13	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+27,500 vol	67,500
Filed 2017-01-27 Tx date 2017-01-26	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 47 - Acquisition or disposition by gift	-7,201 vol	55,167
Filed 2016-12-19 Tx date 2016-12-15	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-235,500 -30,000 vol $7.85 each	115,869
Filed 2016-12-13 Tx date 2016-12-12	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$26,931 +7,201 vol $3.74 each	62,368
Filed 2016-12-13 Tx date 2016-12-12	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-53,867.22 -14,403 vol $3.74 each	88,896
Filed 2016-12-13 Tx date 2016-12-12	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 47 - Acquisition or disposition by gift	$-26,935.48 -7,202 vol $3.74 each	62,368
Filed 2016-12-13 Tx date 2016-12-12	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$26,935 +7,202 vol $3.74 each	69,570
Filed 2016-12-08 Tx date 2016-12-06	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-46,170.30 -12,345 vol $3.74 each	43,000
Filed 2016-12-08 Tx date 2016-12-06	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$29,703 +7,942 vol $3.74 each	12,028
Filed 2016-12-02 Tx date 2016-12-01	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-46,170.30 -12,345 vol $3.74 each	45,265
Filed 2016-12-02 Tx date 2016-12-01	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$29,684 +7,937 vol $3.74 each	12,875
Filed 2016-09-27 Tx date 2016-09-27	$XENE Xenon Pharmaceuticals Inc.	Svoronos, Dawn 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2016-09-27 Tx date 2016-09-27	$XENE Xenon Pharmaceuticals Inc.	Svoronos, Dawn 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+5,144 vol	5,144
Filed 2016-08-23 Tx date 2016-08-19	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-91,337.638 -11,938 vol $7.65 each	145,869
Filed 2016-08-18 Tx date 2016-08-17	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-12,624 -1,600 vol $7.89 each	167,406
Filed 2016-08-18 Tx date 2016-08-18	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-73,912.30 -9,599 vol $7.70 each	157,807
Filed 2016-08-18 Tx date 2016-08-16	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-56,619.75 -6,863 vol $8.25 each	169,006
Filed 2016-08-02 Tx date 2016-07-29	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-12,345 vol	414,420
Filed 2016-08-02 Tx date 2016-07-29	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$28,581 +7,642 vol $3.74 each	211,847
Filed 2016-06-28 Tx date 2016-06-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Holder: Katie Mortimer (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$6,100 +1,000 vol $6.10 each	1,000
Filed 2016-06-28 Tx date 2016-06-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Holder: Katie Mortimer (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$8,190 +1,300 vol $6.30 each	4,300
Filed 2016-06-28 Tx date 2016-06-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Holder: Katie Mortimer (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$12,500 +2,000 vol $6.25 each	3,000
Filed 2016-06-28 Tx date 2014-11-05	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Holder: Katie Mortimer (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-28 Tx date 2016-06-24	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$6,150 +1,000 vol $6.15 each	1,000
Filed 2016-06-28 Tx date 2014-11-05	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-03 Tx date 2016-06-02	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$25,830 +3,500 vol $7.38 each	57,610
Filed 2016-06-03 Tx date 2016-06-02	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$9,225 +1,250 vol $7.38 each	103,299
Filed 2016-06-03 Tx date 2016-06-02	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$25,830 +3,500 vol $7.38 each	102,049
Filed 2016-06-03 Tx date 2016-06-02	$XENE Xenon Pharmaceuticals Inc.	Scheller, Richard Henry 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$25,830 +3,500 vol $7.38 each	11,730
Filed 2016-06-03 Tx date 2016-06-02	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$25,830 +3,500 vol $7.38 each	55,345
Filed 2016-06-03 Tx date 2016-06-02	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$25,830 +3,500 vol $7.38 each	121,190
Filed 2016-06-03 Tx date 2016-06-02	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$25,830 +3,500 vol $7.38 each	69,856
Filed 2016-06-03 Tx date 2016-06-02	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$25,830 +3,500 vol $7.38 each	8,644
Filed 2016-05-27 Tx date 2016-05-25	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Genworks Inc. (Indirect Ownership)	Common Shares 51 - Exercise of options	$30,780 +8,230 vol $3.74 each	18,518
Filed 2016-05-27 Tx date 2016-05-25	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Holder: Genworks Inc. (Indirect Ownership)	Options 51 - Exercise of options	$-30,780.20 -8,230 vol $3.74 each	73,558
Filed 2016-04-29 Tx date 2016-04-28	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 47 - Acquisition or disposition by gift	$-5,770.82 -1,543 vol $3.74 each	98,549
Filed 2016-04-04 Tx date 2016-04-04	$XENE Xenon Pharmaceuticals Inc.	Winquist, Raymond 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+35,000 vol	35,000
Filed 2016-04-04 Tx date 2016-04-04	$XENE Xenon Pharmaceuticals Inc.	Winquist, Raymond 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-11 Tx date 2016-03-11	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+20,000 vol	121,085
Filed 2016-03-11 Tx date 2016-03-11	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+20,000 vol	148,799
Filed 2016-03-11 Tx date 2016-03-11	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+50,000 vol	426,765
Filed 2016-03-11 Tx date 2016-03-11	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+40,000 vol	189,340
Filed 2016-03-11 Tx date 2016-03-11	$XENE Xenon Pharmaceuticals Inc.	Cohen, Charles Jay 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+25,000 vol	120,778
Filed 2016-02-10 Tx date 2016-02-08	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+40,000 vol	40,000
Filed 2016-02-10 Tx date 2016-02-08	$XENE Xenon Pharmaceuticals Inc.	Empfield, James 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2015-12-21 Tx date 2015-12-18	$XENE Xenon Pharmaceuticals Inc.	Mortimer, Ian Charles 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+25,000 vol	149,340
Filed 2015-12-21 Tx date 2015-12-18	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+15,000 vol	128,799
Filed 2015-12-21 Tx date 2015-12-18	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+15,000 vol	101,085
Filed 2015-12-21 Tx date 2015-12-18	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+40,000 vol	376,765
Filed 2015-12-21 Tx date 2015-12-18	$XENE Xenon Pharmaceuticals Inc.	Cohen, Charles Jay 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+15,000 vol	95,778
Filed 2015-12-18 Tx date 2015-12-16	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	$-2,494.77 -411 vol $6.07 each	113,799
Filed 2015-12-18 Tx date 2015-12-16	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$1,104 +182 vol $6.07 each	4,022
Filed 2015-12-14 Tx date 2015-12-11	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$14,986 +2,469 vol $6.07 each	4,938
Filed 2015-12-14 Tx date 2015-12-11	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-14,986.83 -2,469 vol $6.07 each	54,110
Filed 2015-11-25 Tx date 2015-11-24	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-12,485.99 -2,057 vol $6.07 each	117,690
Filed 2015-11-25 Tx date 2015-11-24	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$6,446 +1,062 vol $6.07 each	175,869
Filed 2015-11-06 Tx date 2015-11-02	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 47 - Acquisition or disposition by gift	$-30,598.87 -5,041 vol $6.07 each	100,092
Filed 2015-11-06 Tx date 2015-11-04	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-21,226.79 -3,497 vol $6.07 each	51,845
Filed 2015-11-06 Tx date 2015-11-04	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$9,359 +1,542 vol $6.07 each	4,086
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$8,198 +2,192 vol $3.74 each	21,245
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-7,973 vol	86,870
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-3,115 vol	94,843
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-3,703 vol	97,958
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-6,172 vol	101,661
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-5,144 vol	107,833
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-1,028 vol	112,977
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-785 vol	86,085
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-411 vol	116,062
Filed 2015-09-26 Tx date 2015-09-24	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-103,200 -12,000 vol $8.60 each	6,000
Filed 2015-09-26 Tx date 2015-09-23	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-36,080 -4,000 vol $9.02 each	18,000
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-57,370.17 -6,149 vol $9.33 each	22,000
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$1,650 +618 vol $2.67 each	28,149
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$16,783 +6,286 vol $2.67 each	27,531
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-2,057 vol	114,005
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$1,292 +213 vol $6.07 each	6,316
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$5,411 +1,447 vol $3.74 each	7,763
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$2,704 +723 vol $3.74 each	8,486
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$13,535 +3,619 vol $3.74 each	12,105
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$16,242 +4,343 vol $3.74 each	16,448
Filed 2015-09-26 Tx date 2015-09-22	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$9,742 +2,605 vol $3.74 each	19,053
Filed 2015-08-20 Tx date 2015-08-18	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$10,822 +1,783 vol $6.07 each	3,840
Filed 2015-08-20 Tx date 2015-08-18	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-20,576 vol	336,765
Filed 2015-08-20 Tx date 2015-08-18	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$10,822 +1,783 vol $6.07 each	6,103
Filed 2015-08-20 Tx date 2015-08-18	$XENE Xenon Pharmaceuticals Inc.	Goldberg, Yigal Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-3,085 vol	116,473
Filed 2015-08-20 Tx date 2015-08-18	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$7,217 +1,189 vol $6.07 each	174,807
Filed 2015-08-20 Tx date 2015-08-18	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-2,057 vol	119,747
Filed 2015-08-20 Tx date 2015-08-18	$XENE Xenon Pharmaceuticals Inc.	Pimstone, Simon Neil 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$72,220 +11,898 vol $6.07 each	204,205
Filed 2015-08-20 Tx date 2015-08-18	$XENE Xenon Pharmaceuticals Inc.	Sherrington, Robin Paul 5 - Senior Officer of Issuer Direct Ownership	Options 51 - Exercise of options	-3,085 vol	114,210
Filed 2015-06-19 Tx date 2015-06-17	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	$-9,366.01 -1,543 vol $6.07 each	105,133
Filed 2015-06-19 Tx date 2015-06-17	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$9,366 +1,543 vol $6.07 each	55,167
Filed 2015-05-25 Tx date 2015-05-21	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+5,144 vol	5,144
Filed 2015-05-25 Tx date 2015-05-21	$XENE Xenon Pharmaceuticals Inc.	Gannon, Steven 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2015-05-08 Tx date 2015-01-07	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$15,442 +2,544 vol $6.07 each	2,544
Filed 2015-05-08 Tx date 2015-01-07	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Common Shares 51 - Exercise of options	$21,226 +3,497 vol $6.07 each
Filed 2015-05-08 Tx date 2015-05-04	$XENE Xenon Pharmaceuticals Inc.	Evans, Johnston Livingston 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+3,086 vol	8,230
Filed 2015-05-08 Tx date 2014-11-05	$XENE Xenon Pharmaceuticals Inc.	Evans, Johnston Livingston 4 - Director of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report		5,144
Filed 2015-05-07 Tx date 2015-05-04	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+1,028 vol	106,676
Filed 2015-05-07 Tx date 2015-05-04	$XENE Xenon Pharmaceuticals Inc.	Patou, Gary 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+3,086 vol	55,342
Filed 2015-05-07 Tx date 2015-05-04	$XENE Xenon Pharmaceuticals Inc.	Holler, Frank 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+3,086 vol	121,804
Filed 2015-05-07 Tx date 2015-05-04	$XENE Xenon Pharmaceuticals Inc.	Hayden, Michael R. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+3,086 vol	66,356
Filed 2015-05-07 Tx date 2015-05-04	$XENE Xenon Pharmaceuticals Inc.	Azab, Mohammad 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+3,086 vol	56,579
Filed 2015-05-07 Tx date 2015-05-04	$XENE Xenon Pharmaceuticals Inc.	Tarnow, Michael M. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+3,086 vol	105,648
Filed 2015-05-07 Tx date 2015-05-04	$XENE Xenon Pharmaceuticals Inc.	Scheller, Richard Henry 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	+3,086 vol	8,230
Filed 2015-05-05 Tx date 2015-04-30	$XENE Xenon Pharmaceuticals Inc.	Stein, Evan Albert 4 - Director of Issuer Holder: Stein Family, LLC (Control or Direction)	Common Shares 11 - Acquisition or disposition carried out privately	+909,619 vol	910,586
Filed 2015-05-05 Tx date 2015-04-30	$XENE Xenon Pharmaceuticals Inc.	Stein, Evan Albert 4 - Director of Issuer Holder: Lipoterx Ltd. (Control or Direction)	Common Shares 11 - Acquisition or disposition carried out privately	-1,038,964 vol	0
Filed 2015-05-05 Tx date 2015-04-30	$XENE Xenon Pharmaceuticals Inc.	Stein, Evan Albert 4 - Director of Issuer Holder: Lipoterx Holdings, LLC (Control or Direction)	Common Shares 11 - Acquisition or disposition carried out privately	+4,172 vol	4,172
Filed 2015-05-05 Tx date 2014-11-05	$XENE Xenon Pharmaceuticals Inc.	Stein, Evan Albert 4 - Director of Issuer Holder: Lipoterx Holdings, LLC (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report